Biofourmis

Verified

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech

Company News Biofourmis Team Profile Healthcare Startups Series C Route United States News

About Biofourmis

Biofourmis is tracked on 100Xfounder as a healthcare company, founded in 2015, based in Boston, Massachusetts, USA, currently mapped to the Series C stage. Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech

Profile snapshot: Founders linked: Biofourmis Team. Funding tracked: $100.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

Biofourmis appears in the 100Xfounder startup directory import feed.

Why it Matters

Biofourmis is worth tracking because its funding history is already mapped here, including a $100.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Biofourmis Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $100.00MLast Round: Series C Sequoia, $100M Series C in 2020, $700M valuationAll Rounds: 1

Series C | Sequoia, $100M Series C in 2020, $700M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Biofourmis Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

PythonGCPBigQueryReact

Last updated: May 11, 2026

Biofourmis research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech
Founders covered
Biofourmis Team
Market position
Healthcare | Series C | Boston, Massachusetts, USA
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$100.00M

Best next clicks

Company News Hub Biofourmis Team United States News Healthcare Startups Series C Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Thatch

Thatch Team

View Company Industry Hub

Tempo

Tempo Team

View Company Industry Hub

Neuralink

Neuralink Team

View Company Industry Hub

Cedar

Cedar Team

View Company Industry Hub

SWORD Health

SWORD Health Team

View Company Industry Hub

Scipher Medicine

Scipher Medicine Team

View Company Industry Hub

Calibrate

Calibrate Team

View Company Industry Hub

Forward

Forward Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to Biofourmis.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→United States startup directory→Startups in United States→Healthcare hub→Healthcare startup list→Series C startup list→Series C newsroom→Healthcare startups in United States→Founder directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Biofourmis

Common questions people ask about this profile.

What is Biofourmis?

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech

Who founded Biofourmis?

Biofourmis is associated with Biofourmis Team on 100Xfounder.

Where is Biofourmis located?

Biofourmis is listed in Boston, Massachusetts, USA.

What stage is Biofourmis in?

Biofourmis is currently mapped to Series C. Funding context: Sequoia, $100M Series C in 2020, $700M valuation

What is the latest funding round of Biofourmis?

Biofourmis's latest tracked round is Series C Sequoia, $100M Series C in 2020, $700M valuation. Total tracked rounds: 1.

Is Biofourmis hiring now?

Biofourmis hiring status: Open Roles.

What technologies does Biofourmis use?

Biofourmis is associated with Python, GCP, BigQuery, and React.

Is Biofourmis verified on 100Xfounder?

Yes. Biofourmis is currently marked verified on 100Xfounder as of May 11, 2026.

How can users connect with Biofourmis founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.